Kshirsagar Abhijit V, Bomback Andrew S, Bang Heejung, Gerber Linda M, Vupputuri Suma, Shoham David A, Mazumdar Madhu, Ballantyne Christie M, Paparello James J, Klemmer Philip J
Division of Nephrology and Hypertension, School of Medicine, University of North Carolina, University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA.
Am J Cardiol. 2008 Feb 1;101(3):401-6. doi: 10.1016/j.amjcard.2007.08.041. Epub 2007 Dec 21.
Chronic kidney disease and cardiovascular disease share many risk factors. Injury to the vascular endothelium, measured by elevated levels of serum C-reactive protein (CRP), may play a role in kidney and cardiovascular disease. We therefore examined the association of CRP with microalbuminuria, a marker of early kidney injury. We conducted a cross-sectional analysis of a nationally representative, population-based survey. Weighted multiple logistic regression was used to study the association between CRP and microalbuminuria, adjusting for well-known risk factors. CRP was analyzed by a continuous variable and two categorized variables using quartiles and clinically recommended cutpoints. CRP concentration was positively associated with microalbuminuria. In the multivariate model, a one unit (in milligrams per liter) increase in CRP concentration was associated with a 2% increased odds of microalbuminuria (odds ratio 1.02, 95% confidence interval [CI] 1.01 to 1.02, p=0.0003). When CRP concentrations were stratified by clinically recommended cutpoints, compared with persons with CRP concentrations<1 mg/dl, persons with CRP concentrations between 1 and 3 mg/L and >3 mg/L were 1.15 times (95% CI 0.94 to 1.42) and 1.33 times (95% CI 1.08 to 1.65) more likely to have microalbuminuria, respectively. In subgroup analyses, the strength of association was comparable or stronger. In conclusion, elevated CRP levels were associated with microalbuminuria in a large, nationally representative data set. Vascular inflammation, as measured by CRP, may be a common contributor to early heart and kidney disease.
慢性肾脏病和心血管疾病有许多共同的危险因素。血清C反应蛋白(CRP)水平升高所衡量的血管内皮损伤,可能在肾脏和心血管疾病中起作用。因此,我们研究了CRP与微量白蛋白尿(早期肾损伤的一个标志物)之间的关联。我们对一项具有全国代表性的基于人群的调查进行了横断面分析。采用加权多元逻辑回归研究CRP与微量白蛋白尿之间的关联,并对已知危险因素进行了校正。CRP通过连续变量以及使用四分位数和临床推荐切点的两个分类变量进行分析。CRP浓度与微量白蛋白尿呈正相关。在多变量模型中,CRP浓度每增加一个单位(每升毫克),微量白蛋白尿的发生几率增加2%(比值比1.02,95%置信区间[CI]1.01至1.02,p=0.0003)。当根据临床推荐切点对CRP浓度进行分层时,与CRP浓度<1mg/dl的人相比,CRP浓度在1至3mg/L和>3mg/L之间的人发生微量白蛋白尿的可能性分别高1.15倍(95%CI 0.94至1.42)和1.33倍(95%CI 1.08至1.65)。在亚组分析中,关联强度相当或更强。总之,在一个大型的、具有全国代表性的数据集中,CRP水平升高与微量白蛋白尿相关。以CRP衡量的血管炎症可能是早期心脏和肾脏疾病的一个共同促成因素。